Reports Q2 revenue $127.8M vs. $156.2M last year. “Q2 presented challenges as significant trade disruptions from new tariff measures impacted the broader industry,” said CEO R. Scott Tidey. “Our team responded swiftly with strategic actions, including accelerating our manufacturing diversification, implementing select price increases, and reducing our fixed cost base. While the unprecedented macroeconomic headwinds pressured sales, we were able to lessen the impact on profitability through 160 basis points of gross profit expansion driven by a favorable shift in customer mix including our higher-margin Commercial and Health businesses. Based on our decisive actions to address rapidly changing market conditions, combined with the strength of our brand portfolio, upcoming product launches and new retail placements, we believe we are well positioned to navigate the current environment and emerge with our leadership position intact.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
